Depressive SymptomsNCT06039228
School-based Group Acceptance and Commitment Therapy for Adolescents
A study testing Acceptance and commitment therapy in people with Depressive Symptoms and Anxiety, run by Chinese University of Hong Kong at 1 site in Hong Kong.
Trial summary
The objective of the investigators' mental health promotion intervention premised on the Acceptance and Commitment Therapy (ACT) framework in secondary school settings aims to enhance young people's psychological flexibility and reduce their emotional distress. Read more about this study
- Who is it for?
- Ages 12 to 18 years
- Conditions the study is for
- Depressive Symptoms, Anxiety, Stress
- What is being tested?
- Acceptance and commitment therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 61 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 Jul 2023to 31 Aug 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Eligible participants are adolescents who reported mild to moderate severity of psychological distress, including those who report:
- a score of 5-19 on the Patient Health Questionnaire (PHQ-9), or
- a score of 5-14 on the General Anxiety Disorder-7, or
- a score ≥14 on the Perceived Stress Scale.
Who cannot join
- Adolescents will be excluded if they exhibit or report:
- violent or aggressive behavior, or
- active self-injurious or suicidal thought, or
- active psychotic symptom.
Trial locations and contacts
1 site in 1 country.
Hong Kong1 site
Department of Educational Psychology, The Chinese University of Hong Kong
Shatin
About this study
Official title: Thriving Through the Storms: A School-based Mental Health Promotion Program for Building Psychological Flexibility and Resilience
The objective of the investigators' mental health promotion intervention premised on the Acceptance and Commitment Therapy (ACT) framework in secondary school settings aims to enhance young people's psychological flexibility and reduce their emotional distress. ACT is an evidence-based approach that encourages individuals to act in alignment with their identified values. The investigator's team will employ an ACT protocol for adolescents developed by Louise Hayes and Joseph Ciarrochi. The study includes a single-group study design. The investigator will compare the pre- and post-intervention data to assess the feasibility and potential effectiveness of the group intervention.
- Conditions
- Depressive Symptoms, Anxiety, Stress
- Being tested
- Acceptance and commitment therapy
- Medical subject headings
- Depression, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Acceptance and commitment therapyBehavioural
Four sessions of group acceptance and commitment therapy, with each session lasting for 1.5 hours.
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | Not described Receives: Behavioral: Acceptance and commitment therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptance and Action Questionnaire - II
Measured: Baseline and 4 weeks
The 14-item Resilience Scale
Measured: Baseline and 4 weeks
Patient Health Questionnaire - 9
Measured: Baseline and 4 weeks
General Anxiety Disorder - 7
Measured: Baseline and 4 weeks
Perceived Stress Scale
Measured: Baseline and 4 weeks
Secondary outcomes (2)
Satisfaction with Life Scale
Measured: Baseline and 4 weeks
Pittsburgh Sleep Quality Index
Measured: Baseline and 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Sep 2023
- Study start1 Jul 2023
- Primary completion30 Jun 2024
- Study completion31 Aug 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Depressive SymptomsStudies of the same condition, open and under way.
- More trials run by Chinese University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 61 participants (actual)
Sponsor and investigators
- Lead sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jennifer Yee Man Tang, Chinese University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06039228
- Sponsor's protocol ID
- KPF23GWP12
- Status last verified
- Apr 2026
- First submitted
- 9 Sep 2023
- Last updated
- 17 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Thriving Through the Storms: A School-based Mental Health Promotion Program for Building Psychological Flexibility and Resilience
- ClinicalTrials.gov ID
- NCT06039228
- Acronym / sponsor ID
- KPF23GWP12
- Conditions
- Depressive Symptoms, Anxiety, Stress
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 61 participants (actual)
- Lead sponsor
- Chinese University of Hong KongUniversity, hospital or other
- Study start
- 1 Jul 2023 (actual)
- Primary completion
- 30 Jun 2024 (actual)
- Study completion
- 31 Aug 2024 (actual)
- First posted
- 15 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of the investigators' mental health promotion intervention premised on the Acceptance and Commitment Therapy (ACT) framework in secondary school settings aims to enhance young people's psychological flexibility and reduce their emotional distress. ACT is an evidence-based approach that encourages individuals to act in alignment with their identified values. The investigator's team will employ an ACT protocol for adolescents developed by Louise Hayes and Joseph Ciarrochi. The study includes a single-group study design. The investigator will compare the pre- and post-intervention data to assess the feasibility and potential effectiveness of the group intervention.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Behavioral: Acceptance and commitment therapy |
Who may qualify
- Ages
- 12 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- Eligible participants are adolescents who reported mild to moderate severity of psychological distress, including those who report:
- a score of 5-19 on the Patient Health Questionnaire (PHQ-9), or
- a score of 5-14 on the General Anxiety Disorder-7, or
- a score ≥14 on the Perceived Stress Scale.
Key exclusion criteria (4 listed)
- violent or aggressive behavior, or
- active self-injurious or suicidal thought, or
- active psychotic symptom.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Acceptance and commitment therapyFour sessions of group acceptance and commitment therapy, with each session lasting for 1.5 hours. | Behavioural | Intervention group |
Primary outcome
Acceptance and Action Questionnaire - II
Time frame: Baseline and 4 weeks
The 14-item Resilience Scale
Time frame: Baseline and 4 weeks
Patient Health Questionnaire - 9
Time frame: Baseline and 4 weeks
General Anxiety Disorder - 7
Time frame: Baseline and 4 weeks
Perceived Stress Scale
Time frame: Baseline and 4 weeks
2 secondary outcomes
Satisfaction with Life Scale
Time frame: Baseline and 4 weeks
Pittsburgh Sleep Quality Index
Time frame: Baseline and 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Depressive Symptoms
RecruitingPhase 2
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD)
RecruitingPhase 1
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Healthy Volunteer, Major Depressive Disorder
RecruitingPhase 1
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Vasopressin Deficiency
Recruiting
Psychopharmacotherapy for Depressive Patients
Major Depressive Disorder
RecruitingObservational study
Characterization and Treatment of Adolescent Depression
Depression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Acceptance and commitment therapy in people with Depressive Symptoms and Anxiety, run by Chinese University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptance and Action Questionnaire - II (time frame: Baseline and 4 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2026.